Clinical Trial Update: Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated the duration of Azstarys effects and its impact on adult ADHD symptoms and executive function in the early evening, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Azstarys (serdexmethylphenidate/dexmethylphenidate)

Snippet

Sponsor: NYU Langone Health | Conditions: Adult Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-07-29